MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Genetics"

  • MDS Virtual Congress 2021

    Spinocerebellar ataxia (SCA) type 2 and type 8: a tale of two repeat expansions in a single patient

    J. Frey, T. Tholanikunnel, L. Kugelmann, M. Burns, S. Subramony (Gainesville, USA)

    Objective: To describe the rare occurrence of coexisting SCA Types 2 and 8 in a pediatric patient. Background: SCAs are a group of autosomal dominant…
  • MDS Virtual Congress 2021

    Hot cross bun sign in progressive ataxia with ELVOL4 mutation

    M. Moreno-Escobar, R. Tripathi (Morgantown, USA)

    Objective: To describe a case of progressive gait abnormalities and bulbar dysfunction which was associated with genetic mutation and neuroimaging findings representative of spinocerebellar ataxia…
  • MDS Virtual Congress 2021

    Ataxia in a Puerto Rican woman with a missense variant in the CCDC88 gene

    C. Serrano, J. Abreu, J. Otero (San Juan, Puerto Rico)

    Objective: A 44 years old Puerto Rican woman develops progressive speech difficulties, and cognitive problems. Coordination, balance and gait get affected. Later experienced swallowing problems.…
  • MDS Virtual Congress 2021

    CEREBELLAR COGNITIVE AFFECTIVE SYNDROME IN SPINOCEREBELLAR ATAXIA TYPE 3

    KH. Yap, S. Azmin, SH. Mat Desa, HN. Achok, N. Mohamed Ibrahim (Cheras, Malaysia)

    Objective: This preliminary study aims to examine whether motor and cognitive features in spinocerebellar ataxia type 3 (SCA3) are manifestations of a shared and parallel,…
  • MDS Virtual Congress 2021

    Effects of Gandouling Tablets on the Muscle tone and stiffness of patients with Wilson’s disease: a randomized, double-blind, placebo-controlled study

    W. Hao (Hefei, China)

    Objective: To analyze the effects of Gandouling tablets(GDL) on the tone and stiffness of the biceps brachii muscle in Wilson’s disease (WD) patients, and the correlation between…
  • MDS Virtual Congress 2021

    A Child with Fever-Induced Paroxysmal Weakness and Encephalopathy with ATP1A3 mutation

    D. Ferman, Q. Luc (Los Angeles, USA)

    Objective: We describe a case of fever-induced paroxysmal weakness and encephalopathy (FIPWE), also known as relapsing encephalopathy with cerebellar ataxia (RECA) and expand the phenotypic…
  • MDS Virtual Congress 2021

    Whole-Exome Sequencing in a Movement Disorders Clinic

    C. Shah, L. Robak, E. Hill, J. Jankovic (Houston, USA)

    Objective: To evaluate the diagnostic utility of whole-exome sequencing (WES) in select patients with a movement disorder. Background: Many patients with suspected genetic movement disorders…
  • MDS Virtual Congress 2021

    Be aware of pitfalls: Bioinformatic analysis of Cas9-targeted Nanopore sequencing of the RFC1 repeat in CANVAS

    I. Wohlers, H. Pott, S. Schaake, J. Trinh, H. Busch, K. Lohmann (Lübeck, Germany)

    Objective: To determine the full sequence and length of the pentanucleotide repeat in the RFC1 gene by Cas9-targeted Nanopore sequencing in patients with cerebellar ataxia…
  • MDS Virtual Congress 2021

    PLA2G6-Associated Neurodegeneration: A Continuum of Phenotypes

    D. Shah-Zamora, M. Bailey (Chicago, USA)

    Objective: To characterize the spectrum of phenotypes of PLA2G6-associated neurodegeneration in a single patient. Background: The phospholipase A2 Group VI (PLA2G6) gene encodes a cytosolic and…
  • MDS Virtual Congress 2021

    MOLECULAR-GENETIC ASPECTS OF WILSON’S DISEASE IN UKRAINE

    I. Voloshyn-Haponov (Kharkiv, Ukraine)

    Objective: To assess the features of molecular genetic mutations in the Ukrainian population of patients with Wilson's disease (WD). Background: Molecular genetic research becomes available…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 28
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley